CoQ10 for Statin Users: The Evidence for Ubiquinol
Statins may deplete CoQ10 by up to 40%. Here is the evidence for ubiquinol supplementation — and why the form you choose matters more than the dose on the label.
D.C., Chiropractic Physician
Chiropractic Physician
Dr. Brennan Commerford is a Chiropractic Physician and the founder of FormulaForge — a precision supplement platform built to end the era of one-size-fits-all nutrition.
View Full ProfileMedically Reviewed
This article has been reviewed for medical accuracy by Dr. Brennan Commerford, D.C., Chiropractic Physician
Reviewed by Dr. Brennan Commerford, DC
Statins are among the most widely prescribed medications in the world, and they work by inhibiting HMG-CoA reductase — the same enzyme pathway that produces CoQ10. This shared pathway means that statin therapy can reduce circulating CoQ10 levels by 20-40%, potentially contributing to the muscle symptoms that lead many patients to discontinue their medication. This article reviews the evidence for CoQ10 supplementation in statin users, explains why ubiquinol (the reduced form) absorbs significantly better than ubiquinone, and provides practical guidance on dosing and timing. This is not a case against statins — it is a case for supporting mitochondrial function during statin therapy.
How Statins Deplete CoQ10 (And Why It Matters)
To understand the CoQ10-statin relationship, you need to understand one enzyme: HMG-CoA reductase. This enzyme sits at the top of the mevalonate pathway, which produces both cholesterol and CoQ10. Statins work by inhibiting this enzyme — that is their entire mechanism for lowering cholesterol. But because the same enzyme feeds the CoQ10 production line, statin therapy reduces CoQ10 synthesis as a collateral effect.[1]
CoQ10 (coenzyme Q10, also called ubiquinone in its oxidized form or ubiquinol in its reduced form) is essential for mitochondrial energy production. Every cell in your body uses CoQ10 to generate ATP through the electron transport chain. It is also a potent lipid-soluble antioxidant that protects cell membranes from oxidative damage.
The tissues that depend most on CoQ10 are those with the highest energy demands: the heart, skeletal muscles, liver, and brain. When CoQ10 levels decline — whether from aging, statin use, or both — these tissues are the first to be affected.
The mevalonate pathway that statins inhibit produces both cholesterol and CoQ10. Blocking the enzyme at the top of this pathway (HMG-CoA reductase) is what makes statins effective for cholesterol — but it also means CoQ10 production drops by the same mechanism. This is not a side effect in the traditional sense; it is a direct pharmacological consequence.
Statin-induced CoQ10 depletion is not a fringe concern — it is a well-documented pharmacological consequence of the same mechanism that makes statins work. The question is not whether statins reduce CoQ10, but whether supplementing CoQ10 meaningfully addresses the downstream effects.
Ubiquinol vs Ubiquinone: The Form Debate
CoQ10 exists in two forms in the body: ubiquinone (oxidized) and ubiquinol (reduced). In the mitochondria, the molecule cycles between these two states as it shuttles electrons through the energy production chain. Both forms are available as supplements, but they are not equivalent in terms of absorption.
Ubiquinol is the pre-reduced, bioactive form of CoQ10 — it is what your cells actually use. Your body can convert ubiquinone to ubiquinol, but this conversion becomes less efficient with age and during states of oxidative stress. By supplementing with ubiquinol directly, you bypass this conversion step.
Pharmacokinetic studies have shown that ubiquinol achieves approximately 3.5 times higher plasma levels than ubiquinone at equivalent doses. A 2014 study comparing the two forms found that 150mg of ubiquinol produced plasma CoQ10 levels comparable to 400-500mg of ubiquinone.[2]
- Bioavailability
- ~3.5x higher than ubiquinone
- Primary Use
- Mitochondrial energy, antioxidant defense
- Typical Dose
- 100–200mg daily
- Key Advantage
- Pre-reduced form, ready for cellular use
- Bioavailability
- Lower — requires body conversion
- Primary Use
- Same, but less efficiently delivered
- Typical Dose
- 200–400mg daily
- Conversion
- Declines with age and oxidative stress
What the Clinical Evidence Actually Shows
The clinical evidence for CoQ10 in statin users has been mixed, but several well-designed studies and meta-analyses provide useful guidance.
A 2018 meta-analysis of 12 randomized controlled trials involving 575 statin-treated patients found that CoQ10 supplementation was associated with a significant reduction in statin-associated muscle symptoms (SAMS), including myalgia, weakness, and exercise intolerance. The effect was most pronounced at doses of 100-200mg per day of ubiquinol or 200-400mg per day of ubiquinone.[3]
A 2020 systematic review specifically examining CoQ10 and statin myopathy concluded that while the evidence supports a biological rationale for supplementation, the quality of individual trials varies significantly. The reviewers noted that studies using the ubiquinol form and doses above 100mg/day tended to show larger effect sizes.[4]
The strongest evidence exists for patients who experience statin-associated muscle symptoms. For asymptomatic patients, the evidence for routine supplementation is less compelling but the biological rationale remains — especially in older adults whose endogenous CoQ10 production is already declining.
A meta-analysis of 12 RCTs found that CoQ10 supplementation significantly reduced statin-associated muscle symptoms in treated patients, with the effect most pronounced at doses above 100mg/day of the ubiquinol form. — Qu H et al. Atherosclerosis. 2018.
The Q-SYMBIO trial — a randomized, double-blind study of 420 patients with chronic heart failure — found that CoQ10 supplementation (100mg ubiquinone, 3x daily) was associated with a significant reduction in major adverse cardiovascular events over 2 years. — Mortensen SA et al. JACC Heart Fail. 2014.[5]
Dose, Timing, and Absorption: Getting It Right
CoQ10 is a fat-soluble compound, which means absorption is significantly enhanced when taken with dietary fat. Studies show that taking CoQ10 with a meal containing at least 10-15 grams of fat can increase absorption by 2-3 times compared to taking it on an empty stomach.
Dosing recommendations based on the available evidence:
- Ubiquinol (preferred): 100-200mg per day, taken with the largest meal
- Ubiquinone (if ubiquinol is unavailable): 200-400mg per day, split into two doses with meals
- For active muscle symptoms: Start at the higher end of the range; many practitioners use 200mg ubiquinol for 8-12 weeks before reassessing
Plasma CoQ10 levels typically take 2-4 weeks to reach steady state with daily supplementation. Clinical improvements in muscle symptoms, when they occur, are usually reported at 4-8 weeks.[6]
For statin users, 100-200mg of ubiquinol daily with a fat-containing meal is the evidence-based starting point. Give it at least 4-8 weeks before assessing whether muscle symptoms have improved. Ubiquinone can work but requires roughly 2-3x the dose.
Who Benefits Most from CoQ10 Supplementation
Not every statin user needs CoQ10 supplementation, but certain groups have stronger reasons to consider it:
Strongest rationale: Patients experiencing statin-associated muscle symptoms (pain, weakness, exercise intolerance), patients over 60 (declining endogenous CoQ10 production), patients on high-dose or high-potency statins (atorvastatin 40-80mg, rosuvastatin 20-40mg), and patients with pre-existing mitochondrial concerns.
Reasonable consideration: Asymptomatic statin users who want proactive mitochondrial support, athletes on statins (higher muscle energy demands), and patients with heart failure regardless of statin use (per Q-SYMBIO trial data).
Lower priority: Young, asymptomatic patients on low-dose statins with no muscle complaints. For this group, monitoring is reasonable; routine supplementation is optional.
Most CoQ10 supplements use ubiquinone — the oxidized form that requires enzymatic conversion before your cells can use it. This conversion declines with age, precisely when statin use is most common. The result: the patients who need CoQ10 most are the ones least equipped to convert it from ubiquinone to the active ubiquinol form.
FormulaForge uses ubiquinol (Tier 1) as the default CoQ10 form, delivering approximately 3.5 times the bioavailability of standard ubiquinone. The platform calculates the dose equivalence so you can see exactly how your formula compares to clinical study protocols.
The Conversation You Should Have With Your Doctor
I want to be explicit about something: CoQ10 supplementation is not a reason to stop, reduce, or modify your statin therapy. If your physician has prescribed a statin, it is because the cardiovascular risk-benefit analysis supports it. CoQ10 is a supportive supplement — it addresses a nutritional consequence of statin therapy, not a reason to avoid the therapy itself.
That said, here is what I recommend discussing with your prescribing physician:
- Inform them that you are considering CoQ10 supplementation and why
- Ask whether ubiquinol at 100-200mg daily would be appropriate for your situation
- If you are experiencing muscle symptoms, ask whether CoQ10 depletion might be contributing before switching statins or reducing dose
- Request periodic CoQ10 blood level monitoring if available — though this is not standard practice, it can guide dosing
Most physicians are familiar with the CoQ10-statin relationship and will have an informed opinion. The ones who are not will appreciate you bringing research-backed information to the conversation.
CoQ10 supplementation supports mitochondrial function during statin therapy — it does not replace statin therapy. Always inform your prescribing physician about your supplement regimen, especially when taking medications that affect the same metabolic pathway.
CoQ10 may interact with blood thinners (warfarin) by reducing their effectiveness, as CoQ10 has mild procoagulant properties. If you take anticoagulant medications, discuss CoQ10 supplementation with your prescribing physician before starting. CoQ10 is not a substitute for statin therapy — never discontinue a prescribed medication without medical guidance.
FormulaForge uses ubiquinol as its Tier 1 CoQ10 form. When you build your formula, the platform shows you the bioavailability difference between ubiquinol and ubiquinone, flags anticoagulant interactions, and calculates the dose based on the most relevant clinical studies. Build Your Formula
For a detailed comparison of ubiquinol versus ubiquinone — including absorption curves, dosing equivalence, and cost-per-absorbed-milligram — see our Ubiquinol vs. Ubiquinone Comparison.
Statins reduce CoQ10 production through the same mechanism that lowers cholesterol — this is pharmacology, not controversy. For statin users experiencing muscle symptoms, 100-200mg of ubiquinol daily is a well-supported intervention. Ubiquinol absorbs approximately 3.5 times better than ubiquinone, making it the preferred form — especially for older adults whose CoQ10 conversion capacity is declining. Always coordinate with your prescribing physician.
Frequently Asked Questions
Do all statin users need CoQ10?
Not necessarily. CoQ10 supplementation has the strongest rationale for patients experiencing statin-associated muscle symptoms and for older adults whose endogenous CoQ10 production is declining. Asymptomatic patients on low-dose statins may choose to supplement proactively, but it is not universally recommended as standard of care.
How long does CoQ10 take to work for statin muscle pain?
Plasma CoQ10 levels reach steady state in 2-4 weeks with daily supplementation. Clinical improvements in muscle symptoms are typically reported at 4-8 weeks. Some patients notice changes sooner, while others may need 8-12 weeks at adequate doses before seeing meaningful improvement.
Can I take ubiquinone instead of ubiquinol?
Yes. Ubiquinone is the more widely available and less expensive form. However, you will need a higher dose (roughly 200-400mg) to achieve plasma levels comparable to 100-200mg of ubiquinol. Your body must convert ubiquinone to ubiquinol before cells can use it — a process that becomes less efficient with age.
Should I take CoQ10 in the morning or at night?
CoQ10 is not sedating or stimulating, so timing is flexible. The most important factor is taking it with a meal containing dietary fat to maximize absorption. Most practitioners recommend taking it with your largest meal of the day, which for most people is lunch or dinner.
Does CoQ10 interact with my statin?
CoQ10 does not interfere with statin efficacy. It addresses a downstream nutritional consequence of statin therapy without affecting the cholesterol-lowering mechanism. The two can be taken together safely. However, always inform your prescribing physician about all supplements you take.
Is the CoQ10 depletion from statins clinically significant?
This remains debated. The biochemical depletion (20-40% reduction in circulating CoQ10) is well-documented. Whether this depletion causes symptoms in all patients is less clear. The strongest clinical signal is in patients who develop muscle symptoms, where CoQ10 supplementation has the most consistent evidence of benefit.
For a full comparison of CoQ10 forms, see our Ubiquinol vs. Ubiquinone Comparison and CoQ10 Spotlight.
- Banach M et al. Statin therapy and plasma coenzyme Q10 concentrations — A systematic review and meta-analysis of placebo-controlled trials. Pharmacol Res. 2015;99:329-336.
- Langsjoen PH, Langsjoen AM. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clin Pharmacol Drug Dev. 2014;3(1):13-17.
- Qu H et al. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7(19):e009835.
- Tiniakou E, Duncan JR. The role of coenzyme Q10 in statin-associated myopathy. Curr Opin Rheumatol. 2020;32(6):553-561.
- Mortensen SA et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014;2(6):641-649.
- Skarlovnik A et al. Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study. Med Sci Monit. 2014;20:2183-2188.
This content is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.